Rationale for antioxidant therapy in premature infants to prevent bronchopulmonary dysplasia

Nutrition Reviews

Volumn 59, Issue 1 I, 2001, Pages 10-17

  Welty, S E ^a   Smith, C V ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; COMPLEMENTARY DNA; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE REDUCTASE; RETINOL; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; HUMAN; INFANT; LUNG DYSPLASIA; NONHUMAN; OXIDATION; PREMATURITY; TREATMENT OUTCOME;

ANIMALIA;

EID: 0035127318     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2001.tb01899.x     Document Type: Article

References (57)

1. Pulmonary disease following respirator therapy of hyaline-membrane disease: Bronchopulmonary dysplasia
2. The effect of hyperoxia on superoxide production by lung submitochondrial particles
3. Cellular and subcellular localization of catalase in the heart of transgenic mice
4. 2 release by lung mitochondria and microsome
5. Raised concentration of aldehyde lipid peroxidation products in premature infants with chronic lung disease
6. Breath pentane as a marker for lipid peroxidation and adverse outcome in preterm infants
7. Attenuation in the postnatal expression of the clara cell secreted protein is associated with the development of bronchopulmonary dysplasia
8. Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies
9. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: An international randomized clinical trial
10. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of synthetic surfactant
11. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: A multicenter controlled trial
12. Effects of two rescue doses of a synthetic surfactant on mortality in 700- to 1350-gram infants with respiratory distress syndrome
13. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome
14. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome
15. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group
16. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes
17. Replacement of media in cell culture alters oxygen toxicity: Possible role of lipid aldehydes and glutathione transferases in oxygen toxicity
18. Glutathione-dependent metabolism and detoxification of 4-hydroxy-2-nonenal
19. 2-resistant fibroblasts
20. Elevated protein carbonyls and lipid peroxidation products correlating with myeloperoxidase in tracheal aspirates from premature infants
21. Determination of carbonyl content in oxidatively modified proteins
22. Protein oxidation biomarkers in hyperoxic lung injury in rats: Effects of U-74389
23. Sex differences in diquat-induced hepatic necrosis and DNA fragmentation in Fischer 344 rats
24. Oxidation of proteins in neonatal lungs
25. Prenatal development of lung antioxidant enzymes in four species
26. Development of lung anti-oxidant enzyme system in late gestation: Possible implications for the prematurely born infant
27. 2
28. Immunohistochemical study of copper-zinc and manganese superoxide dismutases in the lungs of human fetuses and newborn infants: Developmental profile and alterations in hyaline membrane disease and bronchopulmonary dysplasia
29. Erythrocyte cupric/zinc superoxide dismutase exhibits reduced activity in preterm and low-birth-weight infants at birth
30. Oxidant stress responses in premature infants during exposure to hyperoxia
31. L-cysteine and glutathione metabolism are impaired in premature infants due to cystathionase deficiency
32. Bronchoalveolar lavage fluid glutathione in intubated premature infants
33. Glutathione metabolism in newborns: Evidence for glutathione deficiency in plasma, bronchoalveolar lavage fluid, and lymphocytes in prematures
34. Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight
35. Vitamin A to prevent bronchopulmonary dysplasia in very-low-birth-weight infants: Has the dose been too low? The NICHD Neonatal Research Network
36. Early vs delayed vitamin A supplementation in very-low-birth-weight infants
37. Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network
38. Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants
39. Antioxidant activity, packed cell transfusions, and outcome in premature infants
40. Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome
41. Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome
42. Improved pulmonary outcome at one year corrected age in premature neonates treated with recombinant human superoxide dismutase
43. Morphometric analysis of the lung in bronchopulmonary dysplasia
44. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen
45. Attenuation in the postnatal expression of the Clara cell secreted protein is associated with the development of bronchopulmonary dysplasia
46. Cloning and tissue-specific expression of the cDNA for the mouse Clara cell 10 kD protein: Comparison of endogenous expression to rabbit uteroglobin promoter-driven transgene expression
47. Transcriptional analysis of the Clara cell secretory protein gene in the mouse transformed Clara cells exposed to hyperoxia
48. Protein content in bronchoalveolar lavage fluid of patients with asthma and control subjects
49. Serum and BAL Clara cell 10 kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers
50. 2 inhibition in vitro
51. Clara cell secretory protein decreases lung inflammation after acute virus infection
52. Expression of human Mn SOD in Chinese hamster ovary cells confers protection from oxidant injury
53. Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury
54. Overexpression of human glutathione reductase in Chinese hamster ovary cells protects cells from oxidant injury
55. Gene transfer of mitochondrially targeted glutathione reductase protects H441 cells from t-butyl hydroperoxide-induced oxidant stresses
56. Attenuation of hyperoxia-induced growth inhibition in H441 cells by gene transfer of mitochondrially targeted glutathione reductase
57. Neonatal chronic lung disease in extremely immature baboons